Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia
about
Demethylating agent decitabine disrupts tumor-induced immune tolerance by depleting myeloid-derived suppressor cells.DNA Methylation Events as Markers for Diagnosis and Management of Acute Myeloid Leukemia and Myelodysplastic Syndrome.Successful treatment of high-risk myelodysplastic syndrome with decitabine-based chemotherapy followed by haploidentical lymphocyte infusion: A case report and literature review.
P2860
Decitabine-based chemotherapy followed by haploidentical lymphocyte infusion improves the effectiveness in elderly patients with acute myeloid leukemia
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Decitabine-based chemotherapy ...... ts with acute myeloid leukemia
@en
type
label
Decitabine-based chemotherapy ...... ts with acute myeloid leukemia
@en
prefLabel
Decitabine-based chemotherapy ...... ts with acute myeloid leukemia
@en
P2093
P2860
P356
P1433
P1476
Decitabine-based chemotherapy ...... ts with acute myeloid leukemia
@en
P2093
Haiyan Zhu
Jihao Zhou
Liping Dou
Lixin Wang
Meiyun Fang
Quanshun Wang
Shimei Lian
P2860
P304
53654-53663
P356
10.18632/ONCOTARGET.11183
P407
P577
2016-08-10T00:00:00Z